|
|
|
Insider
Information: |
Mullen James C |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
227,563 |
|
Indirect Shares
|
75,000 |
|
|
Direct
Value |
$29,809,992 |
|
|
Indirect Value
|
$16,870,500 |
|
|
Total
Shares |
302,563 |
|
|
Total
Value |
$46,680,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
Percentage
Gain/Loss : |
-18.6%
|
-115.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
CEO & President, Direc... |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2014-11-14 |
45,551 |
2004-04-27 |
0 |
Premium* |
|
Patheon NV |
PTHN |
Chief Executive Office... |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
Insulet Corp |
PODD |
Director |
2018-05-16 |
7,783 |
2017-08-09 |
0 |
Premium* |
|
Editas Medicine, Inc. |
EDIT |
CEO, Director |
2022-01-03 |
75,898 |
2018-05-18 |
0 |
Premium* |
|
Thermo Fisher Scientific |
TMO |
Director |
2024-05-22 |
2,828 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
181 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
CEO & President |
|
2006-04-28 |
4 |
AS |
$44.92 |
$392,004 |
D/D |
(8,675) |
0 |
|
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2006-11-16 |
4 |
AS |
$49.95 |
$11,482,557 |
D/D |
(229,877) |
94,252 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2006-11-17 |
4 |
AS |
$49.95 |
$3,502,644 |
D/D |
(70,123) |
94,252 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2006-11-20 |
4 |
AS |
$50.87 |
$8,137,482 |
D/D |
(159,000) |
94,252 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2006-11-27 |
4 |
AS |
$50.99 |
$637,336 |
D/D |
(12,500) |
94,252 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$64.30 |
$7,800,280 |
D/D |
(121,157) |
687,166 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$64.04 |
$4,747,643 |
D/D |
(73,927) |
808,323 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$64.71 |
$12,664,864 |
D/D |
(195,162) |
389,985 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$64.46 |
$6,586,855 |
D/D |
(102,019) |
585,147 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$64.96 |
$12,829,104 |
D/D |
(197,315) |
192,670 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-11 |
4 |
AS |
$65.01 |
$3,663,275 |
D/D |
(56,170) |
136,500 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-14 |
4 |
AS |
$64.95 |
$12,990 |
D/D |
(200) |
136,500 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-04-15 |
4 |
AS |
$64.95 |
$831,360 |
D/D |
(12,800) |
136,500 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2009-12-16 |
4 |
AS |
$50.18 |
$7,378,302 |
D/D |
(147,037) |
112,321 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2010-03-19 |
4 |
AS |
$59.97 |
$20,043,935 |
D/D |
(334,221) |
131,149 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2010-03-22 |
4 |
AS |
$59.95 |
$6,371,724 |
D/D |
(106,279) |
131,149 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2010-11-04 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
32,791 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2004-05-14 |
4 |
B |
$18.33 |
$91,650 |
D/D |
5,000 |
9,020 |
2.39 |
- |
|
PODD |
Insulet Corp |
Director |
|
2017-11-13 |
4 |
B |
$67.45 |
$168,633 |
D/D |
2,500 |
5,598 |
2.39 |
- |
|
EDIT |
Editas Medicine, Inc. |
Director |
|
2018-05-18 |
4 |
B |
$38.03 |
$380,252 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
EDIT |
Editas Medicine, Inc. |
CEO |
|
2021-03-02 |
4 |
B |
$46.27 |
$1,156,800 |
D/D |
25,000 |
35,000 |
2.81 |
% |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2007-02-06 |
4 |
D |
$48.94 |
$933,531 |
D/D |
(19,075) |
30,925 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2007-02-07 |
4 |
D |
$49.32 |
$549,129 |
D/D |
(11,134) |
46,458 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2007-02-13 |
4 |
D |
$49.17 |
$2,052,848 |
D/D |
(41,750) |
174,708 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CEO & President |
|
2008-02-07 |
4 |
D |
$61.58 |
$598,866 |
D/D |
(9,725) |
191,650 |
0 |
- |
|
181 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|